🧪 Retatrutide is changing the game in metabolic research.
As the first triple agonist (GLP-1 + GIP + Glucagon), clinical trials showed up to 24.2% weight loss in 48 weeks — the highest ever reported.
Triple receptor targeting. Unprecedented results.
👉 Explore Retatrutide: altpeptide.com/products.html
#Retatrutide #PeptideResearch #GLP1 #MetabolicResearch #ResearchPeptides